Leadership shift Recent CEO appointment signals strategic refresh and potential for expanded global client engagements in life sciences consulting, favorable for cross-selling regulatory, scientific, and digital transformation services.

Acquisition momentum Series of acquisitions including Stragen Pharma SA, IntiQuan GmbH, Nextep Health, Lifebe, and Strategiqual indicates PLG is expanding capabilities and market reach; identify partner or acquisition-related opportunities to align with clients needing integrated regulatory, pharmacometric, and market access services.

Regulatory powerhouse PLG specializes in regulatory, scientific, compliance, and digital transformation for life sciences; target mid-market to large pharma/biotech firms seeking end‑to‑end regulatory strategy, digitalization, and compliance programs as a service.

Geographic footprint Headquartered in Île-de-France with a global consulting approach; opportunities exist in European markets and expanding life sciences hubs where clients require multilingual regulatory and strategic support across food, cosmetics, nutraceuticals, and medical devices.

Small-to-mid market focus With 11-50 employees and a revenue range under a million, PLG appears agile and selective—ideal for targeted enterprise hunting in niche regulatory segments, digital transformation projects, and strategic market access initiatives that leverage their boutique scale and acquisition-backed growth.